[1]
Malakar, J.; Sen, S.O.; Nayak, A.K.; Sen, K.K. Formulation, optimization and evaluation of transferosomal gel for transdermal insulin delivery. Saudi Pharm. J., 2012, 20, 355-363.
[2]
Harneet, M.; Tarun, G.; Amit, K.; Goyal, R. Permeation enhancer strategies in transdermal drug delivery. Drug Deliv., 2016, 23(2), 564-578.
[3]
Martin, A.; Bustamante, P.; Chun, A.H.C. Physical pharmacy; Lippincott Williams & Wilkins: Philadelphia, 1993, pp. 652-653.
[4]
Schneider, M.; Stracke, F.; Hansen, S.; Schaefer, U.F. Nanoparticles and their interactions with the dermal barrier. Dermatoendocrinol, 2009, 4, 197-206.
[5]
Schmidts, T.; Dobler, D.; Von den Hoff, S.; Schlupp, P.; Garn, H.; Runkel, F. Protective effect of drug delivery systems against the enzymatic degradation of dermally applied DNAzyme. Int. J. Pharm., 2011, 410, 75-82.
[6]
Mezei, M.; Gulasekharam, V. Liposomes- a selective drug delivery system for the topical route of administration I. Lotion dosage form. Life Sci., 1980, 26, 1473-1477.
[7]
Troy, D.B. Remington: The science and practice of pharmacy; Lippincott Williams & Wilkins: Baltimore, 2005, pp. 1018-1025.
[8]
Kirjavainen, M.; Urtti, A.; Ja¨a¨skela¨inen, I.; Suhonen, T.M.; Parone, P.; Valjakka-Koskela, R.; Kiesvaara, J.; Mönkkönen, J. Interaction of liposomes with human skin in vitro – the influence of lipid composition and structure. Acta Biochim. Biophys. Sin., 1996, 1304, 179-189.
[9]
Cevc, G.; Blume, G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Acta Biochim. Biophys. Sin., 1992, 1104, 226-232.
[10]
Cevc, G.; Blume, G.; Scha¨tzlein, A.; Gebaue, D.; Paul, A. The skin: A pathway for systemic treatment with patches and lipid-based agent carriers. Adv. Drug Deliv. Rev., 1996, 18, 349-378.
[11]
Srisuk, P.; Thongnopnua, P.; Raktanochai, U.; Kanokpanon, S. Physicochemical characteristics of ethotrexate-entrapped oleic acid-containing deformable liposomes for in vitro transepidermal delivery targeting psoriasis treatment. Int. J. Pharm., 2012, 427, 426-434.
[12]
Mitragotri, S. Synergistic effect of enhancers for transdermal drug delivery. Pharm. Res., 2000, 17, 1354-1359.
[13]
Hashiguchi, T.; Kodama, A.; Ryu, A.; Otagiri, M. Retention capacity of topical imidazole antifungal agents in the skin. Int. J. Pharm., 1998, 161, 195-204.
[14]
Cevc, G.; Blume, G.; Schatzlein, A. Transferosomesmediated transepidermal delivery improves the regiospecificity and biological activity of corticosteroids in vivo. J. Control. Release, 1997, 45, 211-226.
[15]
Dragicevic-Curic, N.; Gräfe, S.; Gitter, B. et al. Surface charged temoporfin-loaded flexible vesicles: In vitro skin penetration studies and stability. Int. J. Pharm., 2010, 384, 100-108.
[16]
Modi, C.D.; Bharadia, P.D. Transferosomes: A new dominants for transdermal drug delivery. Am. J. Pharm. Tech. Res., 2012, 2, 71-91.
[17]
Benson, H.A. Transferosomes for transdermal drug delivery. Expert Opin. Drug Deliv., 2006, 3, 727-737.
[18]
Patel, B.R.L.; Parikh, R.H. Preparation and formulation of transferosomes containing an antifungal agent for transdermal delivery: Application of Plackett-Burman design to identify significant factors influencing vesicle size. J. Pharm. Bioallied Sci., 2012, 4, 60-61.
[19]
Ishan, G.; Hema, C.; Shashank, G.; Kanchan, K.; Vikash, K. A review of transdermal drug delivery using nano-vesicular carriers: Transferosomes. Recent Pat. Nanomed., 2012, 2, 164-171.
[20]
Inde, V.V.; Jangme, C.M.; Chavan, D.V. A review on transferosome: Is a boon to human life. Int. Res. J. Pharm. Appl. Sci., 2013, 3(2), 174-179.
[21]
Roopesh, S.; Tarun, P. Soniya; Singh V.; Singh, G.; Tyagi, S.; Patel, C.; Gupta, A. Drug carrier transferosomes: A novel tool for transdermal drug delivery system. Int. J. Res. Develop. Pharm. Life Sci., 2013, 2(2), 309-316.
[22]
Walve, J.R.; Bakliwal, S.R.; Rane, B.R.; Pawar, S.P. Transferosomes: A surrogated carrier for transdermal drug delivery system. Int. J. Appl. Biol. Pharm. Technol., 2011, 2, 201-214.
[23]
Reshmy, R.; Shoma, J.; Mukund, V.P.B.; Deepa, T.V. Transferosomes – A vesicular transdermal delivery system for enhanced drug permeation. J. Adv. Pharm. Technol. Res., 2011, 2(3), 138-143.
[24]
Varun, G.; Singh, H.; Bimbrawh, S.; Singh, S.K.; Gulati, M.; Vaidya, Y.; Kaur, P. Ethosomes and transferosomes: Principles, perspectives and practices. Curr. Drug Deliv., 2016, 13, 1-21.
[25]
Singh, N.; Parashar, P.; Tripathi, C.B.; Kanoujia, J.; Kaithwas, G.; Saraf, S.A. Oral delivery of allopurinol niosomes in treatment of gout in animal model. J. Liposome Res., 2017, 12, 21-25.
[26]
Podili, C.; Firoz, S. A review on transferosomes for transdermal drug delivery. J. Glob. Trends Pharm. Sci., 2014, 5(4), 2118-2127.
[27]
Pawar, A.Y.; Jadhav, K.R.; Chaudhari, L.H. Transferosome: A Novel Technique which improves transdermal permeability. Asian J. Pharm., 2016, 10(4), 425-436.
[28]
Shaji, J.; Lal, M. Preparation, optimization and evaluation of transferosomal formulation for enhanced transdermal delivery of a COX-2 inhibitor. Int. J. Pharm. Pharm. Sci., 2014, 6, 467-477.
[29]
Hussain, A.; Samad, A.; Ramzan, M.; Ahsan, M.N.; Rehman, Z.; Ahmad, F.J. Elastic liposome-based gel for topical delivery of 5-fluorouracil: in vitro and in vivo investigation. Drug Deliv., 2014, 7, 1-15.
[30]
Cevc, G.; Blume, G. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, transferosomes. Biochim. Biophys. Acta, 2001, 1514, 191-205.
[31]
Yang, Y.; Ou, R.; Guan, S.; Ye, X.; Hu, B.; Zhang, Y. A novel drug delivery gel of terbinafine hydrochloride with high penetration for external use. Drug Deliv., 2015, 22, 1086-1093.
[32]
Laxmi, M.V.; Zafaruddin, M.D. Design and characterization of transferosomal gel of repaglinide. Int. Res. J. Pharm., 2015, 6, 38-42.
[33]
Alomrani, A.H.; Shazly, G.A.; Amara, A.A. Itraconazolehydroxypropyl-β-cyclodextrin loaded deformable liposomes: In vitro skin penetration studies and antifungal efficacy using Candida albicans as model. Colloids Surf. B Biointerfaces, 2014, 121, 74-85.
[34]
Ahmed, H.; Shuwaili, A.L.; Bazigha, K.; Abdul, R.; Alaa, A.A. Optimization of elastic transferosomes formulations for transdermal 5 delivery of pentoxifylline. Eur. J. Pharm. Biopharm., 2016, 102, 101-114.
[35]
Gupta, A.; Aggarwal, G.; Singla, S.; Arora, R. Transferosomes: A novel vesicular carrier for enhanced transdermal delivery of sertraline: Development, characterization, and performance evaluation. Sci. Pharm., 2012, 80(4), 1061-1080.
[36]
Mohammed, H.K.; Shahira, F.E.M.; Heba, A.; Marwa, H.E. Loratadine bioavailability via buccal transferosomal gel: Formulation, statistical optimization, in vitro/in vivo characterization, and pharmacokinetics in human volunteers. Drug Deliv., 2017, 24(01), 781-791.
[37]
Pathak, K.; Sharma, V.; Sharma, M. Optimization, in vitro cytotoxicity and penetration capability of deformable nanovesicles of paclitaxel for dermal chemotherapy in Kaposi sarcoma. Artif. Cells Nanomed. Biotechnol., 2016, 44, 1671-1683.
[38]
Lin, M-W.; Huang, Y-B.; Chen, C-L.; Wu, P-C.; Chou, C-Y.; Wu, P-C.; Hung, S-Y. A formulation study of 5-aminolevulinic encapsulated in DPPC liposomes in melanoma treatment. Int. J. Med. Sci., 2016, 13, 483-489.
[39]
Dorrani, M.; Garbuzenko, O.B.; Minko, T.; Michniak-Kohn, B. Development of edge-activated liposomes for siRNA delivery to human basal epidermis for melanoma therapy. J. Control. Release, 2016, 228, 150-158.
[40]
Gupta, V.; Karthikeyan, C.; Trivedi, P. Localized delivery of cisplatin for the effective management of squamous cell carcinoma from protransferosome formulation. Arch. Pharm. Res., 2012, 35, 51-859.
[41]
Alam, Zeba. Omer, S.Q.; Chan-Hee, Yua.; Muhammad, A.; Hyung-Seo, K.; Myung-Sic, Kima.; Jong-Ho, K.; Arshad, M.; Sun-Young, C.; Ok-Nam, Baea.; Jin-Ki, Kima. Enhanced anti-rheumatic activity of methotrexate-entrapped ultradeformable liposomal gel in adjuvant-induced arthritis rat model. Int. J. Pharm., 2017, 525(1), 92-100.
[42]
Abdul, Ahad. Abdulmohsen, A.; Abdullah, M.A.; Fahad, I.A.; Mohammad, R.; Alaa, E.; Mohd, A.A. Formulation and characterization of novel soft nanovesicles for enhanced transdermal delivery of eprosartan mesylate. Saudi Pharm. J., 2017, 25(7), 1040-1046.
[43]
Marwa, H.A. Transferosomes as a transdermal drug delivery system for enhancement the antifungal activity of nystatin. Int. J. Pharm. Pharm. Sci., 2013, 5(4), 560-567.
[44]
Patel, R.; Singh, S.K.; Singh, S.; Seth, N.R.; Gendle, R. Development and characterization of curcumin loaded transferosome for transdermal delivery. J. Pharmaceut. Sci. Res., 2009, 1(4), 71-80.
[45]
Vanic, Z.; Hafner, A.; Bego, M.; Skalko-Basnet, N. Characterization of various deformable liposomes with metronidazole. Drug Dev. Ind. Pharm., 2013, 39(3), 481-488.
[46]
Khan, M.A.; Pandit, J.; Sultana, Y.; Sultana, S.; Ali, A.; Aqil, M.; Chauhan, M. Novel carbopolbased transfersomal gel of 5-fluorouracil for skin cancer treatment: In vitro characterization and in vivo study. Drug Deliv., 2015, 22, 795-802.
19
1
